Affinage

DDR1

Epithelial discoidin domain-containing receptor 1 · UniProt Q08345

Length
913 aa
Mass
101.1 kDa
Annotated
2026-06-09
3 papers cited in narrative 3 extracted findings
Cross-family judge vs UniProt: tie

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DDR1 is a collagen receptor kinase that couples engagement of ECM collagen to cytoskeletal and mechanotransduction responses in cancer cells. In dedifferentiated mesenchymal melanoma cells, DDR1 together with DDR2 is activated and drives actomyosin cytoskeleton reorganization and the YAP mechanotransduction pathway in response to ECM stiffness; dual DDR inhibition abrogates this mechano-induced behavior and associated drug resistance, while forced expression of the receptors in melanocytic cells confers mechanical responsiveness and a less differentiated phenotype [PMID:bio_10.1101_2024.08.26.609700]. DDR1 can be selectively engaged in intact cells by type II kinase inhibitors in a manner not always recapitulated in cell-free biochemical assays, indicating that cellular context shapes inhibitor binding [PMID:bio_10.1101_2025.10.09.681452]. Beyond these collagen-driven, mechanotransduction, and inhibitor-engagement findings, no further molecular dissection of DDR1 signaling has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2024 Medium

    Established that DDR1, as a collagen receptor, is an upstream driver of ECM-stiffness-dependent mechanotransduction in dedifferentiated cancer cells rather than a passive adhesion receptor.

    Evidence Pharmacological DDR1/2 inhibition, forced expression in melanocytic cells, collagen-stiffness assays with YAP and phenotypic readouts in melanoma

    PMID:bio_10.1101_2024.08.26.609700

    Open questions at the time
    • Does not separate DDR1 from DDR2 contributions
    • Kinase-dependence and direct molecular link to YAP activation not dissected
    • Preprint, single lab, not peer-reviewed
  2. 2025 Low

    Linked DDR1-collagen engagement to formation of collagen-track membrane structures, proposing a cell-cell communication route that promotes invasion.

    Evidence 3D matrix deposition assays in vitro and in vivo with and without DDR1-ECM interaction, plus functional transfer assays in breast cancer

    PMID:bio_10.1101_2025.01.25.634857

    Open questions at the time
    • No direct mutagenesis or molecular dissection of DDR1's role
    • Single preprint, single lab
    • Mechanism connecting DDR1 signaling to track formation undefined
  3. 2025 Low

    Showed that cellular context governs DDR1 inhibitor binding, since type II inhibitors engage DDR1 in intact cells but not always in cell-free assays.

    Evidence NanoBRET cellular target engagement assay compared against cell-free biochemical kinase panel for TPKI-39 and related inhibitors

    PMID:bio_10.1101_2025.10.09.681452

    Open questions at the time
    • Characterizes inhibitor engagement, not endogenous DDR1 mechanism
    • Structural basis of context-dependent binding unknown
    • Single preprint, single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • How DDR1 kinase activity mechanistically couples collagen binding to YAP activation, cytoskeletal remodeling, and collagen-track formation, and whether these roles are kinase-dependent, remains unresolved.
  • No direct DDR1 substrate or signaling intermediate identified
  • DDR1-specific (vs DDR2) contributions not isolated
  • No structural or biochemical reconstitution of collagen-induced signaling in the corpus

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
No controlled-vocabulary terms were assigned to this entry.

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2024 DDR1 and DDR2 collagen receptors are activated in dedifferentiated mesenchymal melanoma cells and control actomyosin cytoskeleton reorganization and YAP mechanotransduction pathway in response to ECM stiffness; inhibiting both DDR receptors abrogated mechano-induced behavior and drug resistance, while forced expression in melanocytic cells induced mechanical responsiveness and a less differentiated phenotype. Pharmacological inhibition of DDR1/2, forced expression in melanocytic cells, collagen-substrate stiffness assays, YAP pathway readouts, proliferation/migration/drug-resistance phenotypic assays bioRxivpreprint Medium bio_10.1101_2024.08.26.609700
2025 DDR1 interaction with collagen stimulates formation of membrane debris structures (collagen-tracks) left behind migrating breast cancer cells along collagen fibrils, representing a novel cell-cell communication mechanism that promotes invasion. 3D matrix in vitro and in vivo deposition assays, observation of collagen-track formation with and without DDR1-ECM interaction, functional transfer assays bioRxivpreprint Low bio_10.1101_2025.01.25.634857
2025 TPKI-39 engages DDR1 (along with DDR2 and FLT1) selectively in intact cells as characterized by NanoBRET cellular target engagement assays, with DDR1 engagement not observed in cell-free biochemical assays for some type II inhibitors, indicating cellular context influences DDR1 inhibitor binding. NanoBRET cellular target engagement assay, comparison with cell-free biochemical kinase assay panel bioRxivpreprint Low bio_10.1101_2025.10.09.681452

Missed literature

Know a paper Affinage missed for DDR1? Flag it for the maintainers and the community.

No submissions yet.